A Chinese data center developer and operator, a pharmaceutical company focused on disorders of the central nervous system, and a developer of software for customer engagement and digital process automation (up 103%, 180% and 62% year-to-date, respectively) comprise the trio of stocks highlighted in today’s article for their “monster growth” prospects from current levels. For these three stocks where Wall Street analysts see significant upside potential, For more, CLICK HERE.